Corrected QT Interval in Severe Aortic Stenosis: Clinical and Hemodynamic Correlates and Prognostic Impact

Maja Tschumper1, Lukas Weber2, Hans Rickli2

  • 1Cardiology Division, Kantonsspital St. Gallen, St. Gallen, Switzerland; Department of Internal Medicine, Spital Affoltern, Affoltern am Albis, Switzerland.

Insights

In patients with severe aortic stenosis, a prolonged corrected QT interval (QTc) indicates advanced disease and predicts higher mortality after aortic valve replacement. This electrocardiogram finding is a valuable tool for risk stratification in these patients.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology
  • Cardiovascular Disease

Background:

  • The prognostic role of the electrocardiogram (ECG) for risk stratification in severe aortic stenosis (AS) remains unclear.
  • This study investigates the hemodynamic correlates and prognostic significance of the corrected QT interval (QTc) in severe AS patients undergoing aortic valve replacement (AVR).

Purpose of the Study:

  • To evaluate the association between prolonged QTc and hemodynamic parameters in severe AS.
  • To determine the prognostic value of prolonged QTc for long-term mortality after AVR in severe AS patients.

Main Methods:

  • A 12-lead ECG was used to measure the QT interval in 485 severe AS patients prior to cardiac catheterization.
  • Prolonged QTc was defined as >450 ms for men and >470 ms for women. All-cause mortality was the primary outcome measure.

Main Results:

  • Patients with prolonged QTc exhibited more adverse hemodynamic profiles, including larger cardiac chambers, reduced left ventricular ejection fraction, and higher pulmonary pressures.
  • After a median follow-up of 3.7 years post-AVR, prolonged QTc was associated with significantly higher all-cause mortality (HR 2.81; P < .001).
  • Prolonged QTc independently predicted mortality, alongside severe mitral regurgitation and elevated pulmonary vascular resistance.

Conclusions:

  • A prolonged QTc in severe AS patients serves as a marker for advanced disease.
  • This ECG finding is linked to unfavorable hemodynamic characteristics and increased long-term mortality risk following aortic valve replacement.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
241
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
303
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
266
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
159
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
131
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
179